Tanzania Neurology Devices Market Report 2022 to 2030

Tanzania Neurology Devices Market Analysis

$ 3999

The Tanzania neurology device market is expected to witness growth from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. Tanzania has a high prevalence of neurological conditions like seizures, stroke, neurodegenerative diseases, neuromuscular disorders, and neuro-infections. The demand for neurology devices in the nation will rise as these diseases become more common. The market is segmented by product type and by the end user. Some key players in the market include Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Penumbra and Abbott Laboratories.

ID: IN10TZMD012 CATEGORY: Medical Devices GEOGRAPHY: Tanzania AUTHOR: Jigyasu Bhandari

Buy Now

Tanzania Neurology Devices Market Executive Analysis

The Tanzania Neurology Devices Market Size is at around $xx Bn in 2022 and is projected to reach $xx Bn in 2030, exhibiting a CAGR of xx% during the forecast period. The United Republic of Tanzania spent $41 per person on healthcare in 2021. The United Republic of Tanzania saw a rise in health spending per capita from $20 in 2015 to $40 in 2019, growing at an average annual rate of 6.91%. Tanzania's health industry will receive $0.94 billion in 2020, which represents a 0.4% decrease in nominal terms from the $0.93 billion allocated in 2018. The allocation stands for 6.7% of the total national budget and 1.5% of the GDP, down from 7.0% and 1.80%, respectively.

In Tanzania, stroke is the primary cause of mortality and disability, accounting for 6-9% of all casualties. The ageing population, shifts in lifestyle variables, and restricted access to preventive and treatment services all contribute to an increase in the incidence of stroke. With a prevalence of 1-2%, epilepsy is a prominent neurological disease in Tanzania. However, the real prevalence might be higher because of underreporting and restricted access to treatment. The ageing population and shifts in lifestyle factors have led to an increase in the prevalence of neurodegenerative diseases in Tanzania, including Alzheimer's disease and Parkinson's disease. Tanzania also has a high prevalence of neuromuscular illnesses like muscular dystrophy and myasthenia gravis, but there is little knowledge of these diseases and little access to care.

Market Dynamics

Market Growth Drivers

Tanzania has a high prevalence of neurological conditions like seizures, stroke, neurodegenerative diseases, neuromuscular disorders, and neuro-infections. The demand for neurology devices in the nation will rise as these diseases become more common. 60% of Tanzania's population is under 25 years old, and the country is experiencing population growth. The demand for healthcare services, including those pertaining to neurology devices, will be driven by this expanding population. The private sector is showing increasing interest in Tanzania's healthcare industry, including manufacturers of neurology devices. Investments from the private sector will spur innovation, expand access to healthcare, and give manufacturers more openings in Tanzania's market for neurology devices.

Market Restraints

Tanzania's regulatory system for neurology devices is still developing and is still comparatively new. For manufacturers, especially those who are new to the industry, this can present difficulties. Political unrest in Tanzania has a long past, which can be problematic for companies doing business there. Instability in the economy and politics can have an impact on the market for neurology devices.

Competitive Landscape

Key Players

Stryker
Medtronic
Johnson & Johnson
Penumbra
Abbott Laboratories
Philips Healthcare
GE Healthcare

Healthcare Policies and Regulatory Landscape

The Tanzania Food and Drugs Authority (TFDA) is in charge of regulating the market for neurology devices and Tanzania's healthcare policies. The TFDA is in charge of ensuring that medical products adhere to safety and efficacy requirements and are packaged and labelled correctly. The Neurology Devices Regulations, which the government unveiled in 2018, offer a structure for the nation's registration, licencing, and control of neurology devices. Before they can be marketed and distributed in Tanzania, the rules mandate that all neurology devices be registered with the TFDA. Before approving neurology devices for sale, the TFDA evaluates their quality, safety, and effectiveness.

Recent Notable Deals

2020: For the purpose of enhancing Tanzania's healthcare system, GE Healthcare declared in 2020 that it would collaborate with the Ministry of Health of Tanzania. In accordance with the agreement, GE Healthcare agreed to give Tanzanian medical professionals access to neurology devices and training.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Neurology Device Market Segmentation

The Neurology Device Market is segmented as mentioned below:

By Product Type (Revenue, USD Billion):

Neurostimulation
?Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Gastric Electric Stimulation
Interventional Neurology
- Aneurysm Coiling & Embolization
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Cerebral Balloon Angioplasty & Stenting
- Carotid Artery Stents
- Filter Devices
- Balloon Occlusion Devices
- Neurothrombectomy
- Clot Retriever
- Suction Aspiration Devices
- Snares
CSF Management
- CSF Shunts
- CSF Drainage
Neurosurgery Devices
- Ultrasonic Aspirators
- Stereotactic Systems
- Neuroendoscopes
- Aneurysm Clips

By End User (Revenue, USD Billion):

??Hospitals and Clinics
Specialty Centres
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.